Search

1 to 10 of 56
Sort by

Event
SITC CPG Webinar – Case Studies in Immune Checkpoint Inhibitor-related Adverse Events

This webinar is supported, in part, by independent medical education grant funding from Amgen and Merck & Co., Inc. (as of 6/7/21) #ImmuneCheckpointInhibitors #AdverseEvents

 10-06-2021 | 19:00 - 20:00 ET


Event
CPG Webinar – Practical Management Pearls for Immune Checkpoint Inhibitor-related Adverse Events

This webinar is supported, in part, by independent medical education grant funding from Amgen and Merck & Co., Inc. (as of 6/7/21) #ImmuneCheckpointInhibitors #ClinicalPracticeGuideline #AdverseEvents

 09-16-2021 | 11:30 - 12:30 ET


Event
SITC CPG Webinar - Case Studies in Immunotherapy for the Treatment of Lymphoma

On Wednesday, July 7, 2021 from 5:30 – 6:30 pm ET, join leading experts from the SITC Lymphoma Immunotherapy Guideline Expert Panel for the "SITC Clinical Practice Guideline Webinar – Case Studies in Immunotherapy for the Treatment of Lymphoma." This high-level webinar is designed so that...

 07-07-2021 | 17:30 - 18:30 ET


Event
SITC CPG Webinar - Practical Management Pearls for Immunotherapy for the Treatment of Lymphoma

On Monday, June 21, 2021 from 4 – 5 pm ET, join leading experts from the SITC Lymphoma Immunotherapy Guideline Expert Panel for the "SITC Clinical Practice Guideline Webinar – Practical Management Pearls for Immunotherapy for the Treatment of Lymphoma." This high-level webinar is designed so...

 06-21-2021 | 16:00 - 17:00 ET


Event
SITC CPG Webinar – Case Studies in Immunotherapy for the Treatment of Multiple Myeloma

On Wednesday, June 16, 2021 from 5 – 6 pm ET, join leading experts from the SITC Cancer Immunotherapy Guidelines Multiple Myeloma Expert Panel for the "SITC Clinical Practice Guideline Webinar – Case Studies in Immunotherapy for the Treatment of Multiple Myeloma." This high-level webinar is...

 06-16-2021 | 17:00 - 18:00 ET


Library Entry
SITC Clinical Practice Guideline: Immune Effector Cell-related Adverse Events - Recorded Webinar and Presentation Slides

On March 5, 2021, leading experts in cancer immunotherapy presented an overview of the publication "Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events" during a live webinar. The recorded webinar and presentation slides are...

2 attachments


Web Page
SITC Publishes Clinical Immunotherapy Treatment Guidelines for Lymphoma

FOR IMMEDIATE RELEASE Jan. 7, 2021 MILWAUKEE – The Society for Immunotherapy of Cancer (SITC), the world’s leading member-driven organization dedicated solely to cancer immunotherapy, has published a clinical practice guideline for use of immunotherapy in patients with lymphoma, a type of...



Library Entry
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events

Immune effector cell (IEC) therapies offer durable and sustained remissions in significant numbers of patients with hematological cancers. While these unique immunotherapies have improved outcomes for pediatric and adult patients in a number of disease states, as ‘living drugs,’ their toxicity...


Web Page
SITC Publishes Clinical Practice Guideline on Immune Effector Cell-related Adverse Events

FOR IMMEDIATE RELEASE Dec. 18, 2020 MILWAUKEE – The Society for Immunotherapy of Cancer (SITC), the world’s leading member-driven organization dedicated solely to cancer immunotherapy, is pleased to announce the publication of a clinical practice guideline for the management of cell therapy...